NCT01510145View on ClinicalTrials.gov

Efficacy of Changing to TRAVATAN® From Prior Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

191

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Open-angle GlaucomaOcular Hypertension
Interventions
DRUG

Travoprost 0.004% BAK-free

Containing Polyquad (PQ) preservative

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT01510145 - Efficacy of Changing to TRAVATAN® From Prior Therapy | Biotech Hunter | Biotech Hunter